Off-Label Biologic Regimens in Psoriasis: A Systematic Review of Efficacy and Safety of Dose Escalation, Reduction, and Interrupted Biologic Therapy

Open Access

Peer-reviewed

Research Article

Elizabeth A. Brezinski,

Affiliation School of Medicine, University of California Davis, Sacramento, California, United States of America
⨯
April W. Armstrong

* E-mail: aprilarmstrong@post.harvard.edu

Affiliation Department of Dermatology, University of California Davis, Sacramento, California, United States of America
⨯

Reader Comments (0)

Psoriasis
Is the Subject Area "Psoriasis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Systematic reviews
Is the Subject Area "Systematic reviews" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.